Cargando…

Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management

INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, RK, Shah, A, Jalgaonkar, SV, Kerkar, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394530/
https://www.ncbi.nlm.nih.gov/pubmed/37313943
http://dx.doi.org/10.4103/jpgm.jpgm_905_22
_version_ 1785083391355387904
author Tripathi, RK
Shah, A
Jalgaonkar, SV
Kerkar, S
author_facet Tripathi, RK
Shah, A
Jalgaonkar, SV
Kerkar, S
author_sort Tripathi, RK
collection PubMed
description INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients. METHODOLOGY: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40–70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting. RESULTS: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs. CONCLUSION: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented.
format Online
Article
Text
id pubmed-10394530
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-103945302023-08-03 Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management Tripathi, RK Shah, A Jalgaonkar, SV Kerkar, S J Postgrad Med Original Article INTRODUCTION: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients. METHODOLOGY: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40–70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting. RESULTS: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs. CONCLUSION: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented. Wolters Kluwer - Medknow 2023 2023-06-13 /pmc/articles/PMC10394530/ /pubmed/37313943 http://dx.doi.org/10.4103/jpgm.jpgm_905_22 Text en Copyright: © 2023 Journal of Postgraduate Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tripathi, RK
Shah, A
Jalgaonkar, SV
Kerkar, S
Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title_full Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title_fullStr Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title_full_unstemmed Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title_short Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management
title_sort evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: determinants of glaucoma management
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394530/
https://www.ncbi.nlm.nih.gov/pubmed/37313943
http://dx.doi.org/10.4103/jpgm.jpgm_905_22
work_keys_str_mv AT tripathirk evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement
AT shaha evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement
AT jalgaonkarsv evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement
AT kerkars evaluationofantiglaucomadrugtreatmentawarenessandpatientreportedmedicationadherencedeterminantsofglaucomamanagement